Edwards Lifesciences Corporation (EW)

104.80 0.59%
Aug 15 close; Powered by IEX
Pros
Buy analyst rating
Average analyst stock price above current stock price
Cons
Company’s profitability is declining
Forward P/E ratio high relative to industry peers
Forward P/B ratio high relative to industry peers
Forward P/S ratio high relative to industry peers
Forward PEG ratio high relative to industry peers

Pros

  1. EW average analyst rating is Buy. See EW analyst rating chart.
  2. EW average analyst price target ($117.35) is above its current price ($99.45). See EW price target chart.

Cons

  1. EW profitability is declining. The YoY profit margin change was -2.23 percentage points. See EW profitability chart.
  2. EW forward P/E ratio is 38.97, which is high compared to its industry peers’ P/E ratios. See EW forward P/E ratio chart.
  3. EW Price/Book ratio is 11.33, which is high compared to its industry peers’ P/B ratios. See EW forward Price/Book ratio chart.
  4. EW Price/Sales ratio is 11.72, which is high compared to its industry peers’ P/S ratios. See EW forward Price/Sales ratio chart.
  5. EW PEG ratio (P/E adjusted for growth) is 2.65, which is high compared to its industry peers’ PEG ratios. See EW PEG chart.